Literature DB >> 9579721

Quantification and distribution of alpha1-adrenoceptor subtype mRNAs in human proximal urethra.

K Nasu1, N Moriyama, R Fukasawa, G Tsujimoto, T Tanaka, J Yano, K Kawabe.   

Abstract

1. We performed RNase protection assays and in situ hybridization to investigate the ratio of the three alpha1-adrenoceptor subtype mRNAs, alpha1a, alpha1b and alpha1d, in human proximal urethra, and their localization in urethral cross-sections. As revealed by the RNase protection assays, alpha1a was the predominant subtype mRNA in both male and female urethral samples. Alpha1d mRNA was detected only in the female sample, and alpha1b mRNA was not detected in any of the samples tested. The ratio of the abundance of the subtype mRNAs, alpha1a:alpha1b:alpha1d, was 100:0:0 in the male urethra and 90:0:10 in the female urethra. 2. In situ hybridization studies showed no significant differences in the cross-sectional distribution of alpha1-adrenoceptor subtype mRNAs between male and female urethras. Intense alpha1a staining was observed in the smooth muscle of the urethra, but alpha1b and alpha1d staining was much less intense. 3. Of the three cloned alpha1 subtypes, alpha1a is the most likely to be responsible for the contraction of the human urethra. Owing to the side effects of nonselective alpha1 drugs, alpha1-selective drugs may be clinically superior to nonselective drugs for the treatment of urethral disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579721      PMCID: PMC1565293          DOI: 10.1038/sj.bjp.0701731

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  α1-adrenergic receptor antagonists versus placebo for female lower urinary tract symptoms: A meta-analysis.

Authors:  Peng Zhang; Wan-Li Hu; Bei Cheng; Long Cheng; Xiao-Kan Xiong
Journal:  Exp Ther Med       Date:  2015-04-23       Impact factor: 2.447

Review 2.  Phenotype pharmacology of lower urinary tract α(1)-adrenoceptors.

Authors:  A Nishimune; H Yoshiki; J Uwada; A S M Anisuzzaman; H Umada; I Muramatsu
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 3.  Pharmacotherapy for stress urinary incontinence : present and future options.

Authors:  Norman R Zinner; Stephanie C Koke; Lars Viktrup
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Effect of extended-term estrogen on voiding in a postpartum ovariectomized rat model.

Authors:  Narihiko Hayashi; Anthony J Bella; Guifang Wang; Guiting Lin; Donna Y Deng; Lora Nunes; Tom F Lue
Journal:  Can Urol Assoc J       Date:  2007-09       Impact factor: 1.862

Review 5.  Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.

Authors:  Martin C Michel; Wim Vrydag
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 6.  Pharmacotherapy of urinary incontinence.

Authors:  Anastasios Athanasopoulos; Petros Perimenis
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-11-12

7.  Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockade.

Authors:  E C Alexandre; L R Kiguti; F B Calmasini; F H Silva; K P da Silva; R Ferreira; C A Ribeiro; F Z Mónica; A S Pupo; E Antunes
Journal:  Br J Pharmacol       Date:  2016-01-15       Impact factor: 8.739

Review 8.  Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia.

Authors:  Masaki Yoshida; Junzo Kudoh; Yukio Homma; Kazuki Kawabe
Journal:  Clin Interv Aging       Date:  2011-06-22       Impact factor: 4.458

Review 9.  The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia.

Authors:  Jason Gandhi; Steven J Weissbart; Noel L Smith; Steven A Kaplan; Gautam Dagur; Anna Zumbo; Gargi Joshi; Sardar Ali Khan
Journal:  Transl Androl Urol       Date:  2017-04

10.  Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: a 8-week prospective study.

Authors:  Kyu-Sung Lee; Deok Hyun Han; Young-Suk Lee; Myung-Soo Choo; Tag Keun Yoo; Heung Jae Park; Hana Yoon; Hyeon Jeong; Sun Ju Lee; Hayoung Kim; Won Hee Park
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.